Search filters

List of works by Daniela S Thommen

A Variant of a Killer Cell Immunoglobulin-like Receptor Is Associated with Resistance to PD-1 Blockade in Lung Cancer

scientific article published on 14 February 2019

A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade

scientific article published on 11 June 2018

Agonistic anti-CD40 therapy synergizes with LAG-3-blocking antibodies

scientific article published in August 2017

Anti-Inflammatory Drugs Remodel the Tumor Immune Environment to Enhance Immune Checkpoint Blockade Efficacy

publication published on 24 May 2021

Antibody phage display assisted identification of junction plakoglobin as a potential biomarker for atherosclerosis

scientific article

CD8+ T cell states in human cancer: insights from single-cell analysis

scientific article published on 05 February 2020

Cancer immunology - development of novel anti-cancer therapies

scientific article

Digital image analysis improves precision of programmed death ligand 1 (PD-L1) scoring in cutaneous melanoma

scientific article published on 16 April 2018

Expression of inhibitory receptors on intratumoral T cells modulates the activity of a T cell-bispecific antibody targeting folate receptor

scientific article published on 24 June 2015

NK cells with tissue-resident traits shape response to immunotherapy by inducing adaptive antitumor immunity

scientific article published in 2022

Progression of Lung Cancer Is Associated with Increased Dysfunction of T Cells Defined by Coexpression of Multiple Inhibitory Receptors

scientific article published on 7 August 2015

Rationalizing the pathway to personalized neoadjuvant immunotherapy: the Lombard Street Approach

scientific article published on 01 August 2020

Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells

Single-cell analysis of regions of interest (SCARI) using a photosensitive tag

scientific article published on 09 September 2021

T Cell Dysfunction in Cancer.

scientific article published in April 2018

The microtubule-depolymerizing agent ansamitocin P3 programs dendritic cells toward enhanced anti-tumor immunity.

scientific article

Trastuzumab emtansine (T-DM1) renders HER2+ breast cancer highly susceptible to CTLA-4/PD-1 blockade

scientific article published in November 2015

Tumor-derived TGF-β inhibits mitochondrial respiration to suppress IFN-γ production by human CD4+ T cells

scientific article published on 17 September 2019

Two Preferentially Expressed Proteins Protect Vascular Endothelial Cells from an Attack by Peptide-Specific CTL

scientific article published on April 27, 2012